⌘K

Login Start Free

Home/Filings/4/0001415889-25-018275

4//SEC Filing

DANIELS BRIAN 4

Accession 0001415889-25-018275

CIK 0001817241other

View on SEC.gov Company Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:30 PM ET

Size

5.4 KB

Accession

0001415889-25-018275

Insider Transaction Report

Form 4

Period: 2025-06-24

Artiva Biotherapeutics, Inc.ARTV

Director

Transactions

Award
Director Stock Option (Right to Buy)
2025-06-24+13,750→ 13,750 total
Exercise: $1.61Exp: 2035-06-23→ Common Stock (13,750 underlying)

Footnotes (1)

[F1]The shares subject to the option will vest in full on the earlier of June 24, 2026, or the date of the Issuer's 2026 annual stockholder meeting.

Documents

1 file

4
form4-06262025_040601.xmlPrimary

Issuer

Artiva Biotherapeutics, Inc.

CIK 0001817241

Entity typeother

Related Parties

1

filerCIK 0001428698

Filing Metadata

Form type: 4
Filed: Jun 25, 8:00 PM ET
Accepted: Jun 26, 4:30 PM ET
Size: 5.4 KB

View on SEC.gov